Lidds AB (FRA:5LD) ROA %: -148.97% (As of Sep. 2025)


What is Lidds AB ROA %?

Lidds AB FRA:5LD ROA % is -148.97% as of Sep. 2025. The stock has 2 warning signs investors should review.

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Lidds AB's annualized Net Income for the quarter that ended in Sep. 2025 was €-0.32 Mil. Lidds AB's average Total Assets over the quarter that ended in Sep. 2025 was €0.22 Mil. Therefore, Lidds AB's annualized ROA % for the quarter that ended in Sep. 2025 was -148.97%.

The historical rank and industry rank for Lidds AB's ROA % or its related term are showing as below:

FRA:5LD' s ROA % Range Over the Past 10 Years
Min: -184.54   Med: -70.79   Max: -5.94
Current: -75.94

During the past 13 years, Lidds AB's highest ROA % was -5.94%. The lowest was -184.54%. And the median was -70.79%.

FRA:5LD's ROA % is not ranked
in the Biotechnology industry.
Industry Median: -32.87 vs FRA:5LD: -75.94

Lidds AB  (FRA:5LD) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Sep. 2025 )
=Net Income/Total Assets
=-0.324/0.2175
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.324 / 0)*(0 / 0.2175)
=Net Margin %*Asset Turnover
=N/A %*0
=-148.97 %

Note: The Net Income data used here is four times the quarterly (Sep. 2025) net income data. The Revenue data used here is four times the quarterly (Sep. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Lidds AB ROA % Related Terms


Lidds AB ROA % Historical Data

* Premium members only.

The historical data trend for Lidds AB's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lidds AB ROA % Chart

Lidds AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -86.16 -67.59 -86.32 -182.62 -48.09

Lidds AB Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -35.78 -51.05 -89.89 -70.99 -148.97

FRA:5LD vs VRTX, REGN, ALNY: ROA % Comparison

For the Biotechnology subindustry, Lidds AB's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lidds AB ROA % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lidds AB's ROA % distribution charts can be found below:

* The bar in red indicates where Lidds AB's ROA % falls into.



Lidds AB ROA % Calculation

Lidds AB's annualized ROA % for the fiscal year that ended in Dec. 2024 is calculated as:

ROA %=Net Income (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=-0.516/( (1.578+0.568)/ 2 )
=-0.516/1.073
=-48.09 %

Lidds AB's annualized ROA % for the quarter that ended in Sep. 2025 is calculated as:

ROA %=Net Income (Q: Sep. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Sep. 2025 ))/ count )
=-0.324/( (0.255+0.18)/ 2 )
=-0.324/0.2175
=-148.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2025) net income data. ROA % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROA % →
What does a ROA % of -148.97% mean?
Lidds AB (FRA:5LD) has a ROA % of -148.97% as of Sep. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Lidds AB and its competitors.
Is Lidds AB's ROA % too high?
Lidds AB's current ROA % is -148.97%.
How does Lidds AB's ROA % compare to VRTX and REGN?
Lidds AB's ROA % of -148.97% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Biotechnology company?
A good ROA % depends on the Biotechnology industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Lidds AB and its competitors. Lidds AB's current ROA % is -148.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lidds AB stock overvalued right now?
Lidds AB (FRA:5LD) has a current ROA % of -148.97%. The current ROA % is -148.97%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Lidds AB (FRA:5LD), the current ROA % is -148.97% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lidds AB Business Description

Address c/o Excore, Kungsportsavenyen 22, Goteborg, SWE, 411 36
Lidds AB is a Sweden-based drug delivery company focused on its proprietary NanoZolid technology platform. The NanoZolid system is used to formulate drugs for local administration with controlled and sustained release over extended periods. The company offers this technology to partners and is also developing its own pipeline of drug candidates, prominently in oncology, where the platform is used to enable localized and sustained drug delivery. It has a pipeline with several projects in clinical development, both in early- and late-stage clinical phases, and projects about to enter clinical development.